Inhibitors | Comment | Organism | Structure |
---|---|---|---|
CAY10400 | - |
Rattus norvegicus | |
OMDM2 | 0.01 mM, 16% inhibition | Rattus norvegicus | |
UCM707 | - |
Rattus norvegicus | |
URB597 | - |
Rattus norvegicus | |
VDM11 | - |
Rattus norvegicus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
anandamide + H2O | Rattus norvegicus | - |
arachidonic acid + ethanolamine | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
RBL-2H3 cell | basophilic leukemia cell. Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase | Rattus norvegicus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
anandamide + H2O | - |
Rattus norvegicus | arachidonic acid + ethanolamine | - |
? |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0000005 | - |
- |
Rattus norvegicus | CAY10400 | |
0.000002 | - |
- |
Rattus norvegicus | URB597 | |
0.005 | - |
- |
Rattus norvegicus | VDM11 | |
0.05 | - |
- |
Rattus norvegicus | UCM707 |